Long-Term Administration of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Reduces Arterial FDG Uptake

JACC-CARDIOVASCULAR IMAGING

ELSEVIER SCIENCE INC

1. project The Greek research infrastructure for personalized medicine (pMED-GR) - Operational Programme Competitiveness, Entrepreneurship and Innovation (NSRF 2014-2020) [MIS 5002802]
2. European Union (European Regional Development Fund)
3. Amgen
4. Elpen
5. MSD
6. Mylan
7. Sanofi
8. Servier
9. Angelini
10. Lilly
11. Vianex
12. Bayer
13. Menarini